The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Stability of Protein Pharmaceuticals
Manning, M. C., Patel, K., & Borchardt, R. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015929109894 · Cited by 1,078
Aluminum compounds as vaccine adjuvants
Gupta, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00008-8 · Cited by 623
Self-citationStabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Self-citationAdjuvants for human vaccines—current status, problems and future prospects
Gupta, R. K., & Siber, G. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00011-o · Cited by 551
Self-citationAdjuvants — a balance between toxicity and adjuvanticity
Gupta, R. K., Relyveld, E. H., Lindblad, E. B., Bizzini, B., Ben-Efraim, S., & Gupta, C. K. (1993) · Vaccine · doi:10.1016/0264-410x(93)90190-9 · Cited by 545
Self-citationSingh, M., & O'Hagan, D. (1999) · Nature Biotechnology · doi:10.1038/15058 · Cited by 506
Improving protein therapeutics with sustained-release formulations
Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 460
Vaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Hydrogels in controlled release formulations: Network design and mathematical modeling
Lin, C.-C., & Metters, A. T. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.004 · Cited by 1,768
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Biocompatibility of engineered nanoparticles for drug delivery
Naahidi, S., Jafari, M., Edalat, F., Raymond, K., Khademhosseini, A., & Chen, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.013 · Cited by 809
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
Wischke, C., & Schwendeman, S. P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.042 · Cited by 790
Self-citationInjectable matrices and scaffolds for drug delivery in tissue engineering
Kretlow, J. D., Klouda, L., & Mikos, A. G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.013 · Cited by 629
Nanotechnology in vaccine delivery
Peek, L. J., Middaugh, C. R., & Berkland, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.017 · Cited by 562
An overview of clinical and commercial impact of drug delivery systems
Anselmo, A. C., & Mitragotri, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.053 · Cited by 520
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.11.010 · Cited by 467
Polymeric Multilayer Capsules in Drug Delivery
De Cock, L. J., De Koker, S., De Geest, B. G., Grooten, J., Vervaet, C., Remon, J. P., Sukhorukov, G. B., & Antipina, M. N. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906266 · Cited by 460
Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W. (2009) · Nature Materials · doi:10.1038/nmat2444 · Cited by 438
Controlled drug delivery in tissue engineering
Biondi, M., Ungaro, F., Quaglia, F., & Netti, P. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.038 · Cited by 412
Targeting dendritic cells with biomaterials: developing the next generation of vaccines
Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.005 · Cited by 406
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
Polymeric multilayer capsules for drug delivery
De Koker, S., Hoogenboom, R., & De Geest, B. G. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15296g · Cited by 383
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy
Broaders, K. E., Cohen, J. A., Beaudette, T. T., Bachelder, E. M., & Fréchet, J. M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901592106 · Cited by 308
Larsen, C., Østergaard, J., Larsen, S. W., Jensen, H., Jacobsen, S., Lindegaard, C., & Andersen, P. H. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21346 · Cited by 301
Vaccine adjuvants: Current challenges and future approaches
Wilson-Welder, J. H., Torres, M. P., Kipper, M. J., Mallapragada, S. K., Wannemuehler, M. J., & Narasimhan, B. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21523 · Cited by 296
Silk microspheres for encapsulation and controlled release
Wang, X., Wenk, E., Matsumoto, A., Meinel, L., Li, C., & Kaplan, D. L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.021 · Cited by 293
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Kanchan, V., & Panda, A. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.08.015 · Cited by 283
MAO, S., XU, J., CAI, C., GERMERSHAUS, O., SCHAPER, A., & KISSEL, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.036 · Cited by 283
Nicolete, R., Santos, D. F. D., & Faccioli, L. H. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.014 · Cited by 261
Nanoparticles and microparticles as vaccine-delivery systems
Singh, M., Chakrapani, A., & O’Hagan, D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.797 · Cited by 259
Tian, Y., Jiang, X., Chen, X., Shao, Z., & Yang, W. (2014) · Advanced Materials · doi:10.1002/adma.201403562 · Cited by 258
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Controlling timing and location in vaccines
Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 254
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery
Rajapaksa, T. E., Stover-Hamer, M., Fernandez, X., Eckelhoefer, H. A., & Lo, D. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.033 · Cited by 137
Inhibition of Peptide Acylation in PLGA Microspheres with Water-soluble Divalent Cationic Salts
Zhang, Y., Sophocleous, A. M., & Schwendeman, S. P. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9914-2 · Cited by 49
Self-citationA study on in vitro degradation behavior of a poly(glycolide-co-l-lactide) monofilament
Deng, M., Chen, G., Burkley, D., Zhou, J., Jamiolkowski, D., Xu, Y., & Vetrecin, R. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.03.011 · Cited by 41
Robin, B., Albert, C., Beladjine, M., Legrand, F.-X., Geiger, S., Moine, L., Nicolas, V., Canette, A., Trichet, M., Tsapis, N., et al. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.03.061 · Cited by 40
Improved Immunogenicity of Biodegradable Polymer Particles Entrapped Rotavirus Vaccine
Nayak, B., Ray, A. R., Panda, A. K., & Ray, P. (2011) · Journal of Biomaterials Applications · doi:10.1177/0885328209353642 · Cited by 10
Metadata
- Authors
- JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2005-01-10
- Volume
- 57
- Issue
- 3
- Pages
- 391-410
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1985786449
- Cited by
- 478
- References
- 109
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.